431-440 of 858 results for 'consumer data right'

Amendments to the Designs Act: grace yourselves
Insight 28 Oct 2021

Now is the time to review your organisation's strategy for registering and filing designs after the Designs Amendment (Advisory Council on Intellectual Property Response) Act 2021 (Cth) (the Amending Act) received Royal Assent on 10 September 2021. ...

Protecting critical minerals R&D for future success
Insight 24 Feb 2025

An opportunity for Australian businesses to lead the global energy transition ...

An interlocutory injunction outcome you wouldn't have bet on
Insight 23 Aug 2018

Crownbet's efforts to rebrand itself as 'Sportingbet' suffered a blow after Sportsbet successfully applied for an interlocutory injunction in the Federal Court of Australia. ...

Dealing in data: cybersecurity in an M&A context
Insight 17 Oct 2018

The cyber resilience of companies and their history of data breaches is increasingly having a significant impact on the headline price post-completion deal value and risk-allocation profile of MA transactions With the notifiable data-breach scheme and the GDPR taking effect earlier this year there ...

Regulating crypto – token mapping consultation paper hints at future licensing regime
Insight 08 Feb 2023

The Australian Government published its consultation paper Token Mapping. In this Insight, we provide an overview of the Government's proposed approach and how it will impact regulatory reform in the crypto-asset sector. ...

InIP: What's happening in intellectual property - December 2023
Insight 14 Dec 2023

Your regular wrap-up of some of the world's leading and intriguing IP stories. ...

Protecting innovation without patents - data exclusivity and market exclusivity
Insight 19 Jul 2016

Developments in patent law and the consequential limitations on patentability for biologic medicines mean that data exclusivity and market exclusivity can be the primary protection afforded to originator biologic medicines This is most stark in the US where patent protection for biologic medicines ...

Transparency and Accountability - and not just for Wall Street
Insight 07 Mar 2016

The regulatory law repercussions of the GFC remain endlessly fascinating As an example take the Dodd-Frank Wall Street Reform and Consumer Protection Act 2010 It runs to 848 pages Title VII addresses perhaps optimistically Wall Street Transparency and Accountability My favourite provision is section ...

Reasonable belief or a mere suspicion? Full Court lowers the bar on preliminary discovery applications
Insight 11 Dec 2017

The Full Federal Court has handed down a significant decision on preliminary discovery in a result that will be welcomed by IP owners, as the court has clarified the requirements for a successful preliminary discovery application while emphasising the need for such applications to be met with brevit ...

Lawyer or language model? Testing AI’s competence in answering Australian legal questions
Insight 27 May 2024

The last 24 months have seen generative artificial intelligence (AI) tools advance in leaps and bounds, powered by remarkable developments in large language models (LLMs). Their new capabilities are already having significant impact on the way firms operate, including the legal function. ...

Refine